Soru

Zorluk: ZorAnxiety, OCD, and Trauma-Related Disorders

A 28-year-old woman is brought to the clinic by her sister due to profound behavioral changes over the past 5 weeks. Six weeks ago, the patient was sexually assaulted at a social gathering. She has not reported the incident to law enforcement and explicitly asks the physician to keep the event completely confidential. The patient describes experiencing intense, intrusive flashbacks of the assault and has actively avoided leaving her apartment. She exhibits an exaggerated startle response and reports severe insomnia. Her past psychiatric history is significant for a hospitalization at age 22 for a distinct episode of elevated mood, decreased need for sleep, and grandiosity. She currently takes lithium for maintenance therapy. She also mentions that she recently started taking over-the-counter St. John's wort to help manage her current distress. Vital signs and physical examination are unremarkable. Which of the following is the most appropriate next step in the management of this patient?

  1. Refer the patient for trauma-focused cognitive-behavioral therapyCevap
  2. B
    Notify local law enforcement authorities regarding the assault
  3. C
    Add fluoxetine to her current daily medication regimen
  4. D
    Discontinue lithium and initiate citalopram monotherapy
  5. E
    Diagnose brief psychotic disorder and initiate haloperidol therapy

Cevap

Refer the patient for trauma-focused cognitive-behavioral therapy
This patient's clinical presentation—intrusive flashbacks, active avoidance of the outside world, hyperarousal (insomnia, exaggerated startle), and duration of symptoms for over 1 month following a sexual assault—meets the diagnostic criteria for post-traumatic stress disorder (PTSD). Trauma-focused cognitive-behavioral therapy (such as prolonged exposure or cognitive processing therapy) is a definitive first-line treatment for PTSD. In this specific patient, psychotherapy is the most appropriate and safest next step due to her complex pharmacological profile. She has Bipolar I disorder (evidenced by her prior hospitalization for mania) and is taking over-the-counter St. John's wort. Initiating psychopharmacotherapy for PTSD (typically SSRIs or SNRIs) would introduce unacceptable risks of either a manic switch or serotonin syndrome.

Adım Adım Çözüm

1
Identify the primary psychiatric diagnosis based on the clinical presentation and timeline.
The patient has intrusive flashbacks, avoidance, hyperarousal, and negative mood alterations lasting over 1 month following a traumatic event, confirming Post-Traumatic Stress Disorder (PTSD).
Accurate diagnosis is required to guide treatment; the 5-week timeline explicitly rules out Acute Stress Disorder.
2
Analyze the patient's comorbidities and current medication profile.
The patient has Bipolar I Disorder (prior hospitalization for mania) managed with lithium, and is concurrently taking St. John's wort.
Comorbidities and supplements dictate pharmacological contraindications.
3
Evaluate standard PTSD treatments against the patient's specific risk factors.
SSRIs are first-line pharmacological options for PTSD, but in this patient, they pose a dual risk: Serotonin Syndrome (due to St. John's wort) and manic switch (if given as monotherapy for Bipolar I).
Psychopharmacologic interventions must 'do no harm' by avoiding dangerous drug-drug and drug-disease interactions.
4
Select the safest, most effective first-line management strategy.
Trauma-focused cognitive-behavioral therapy is definitively first-line for PTSD and carries zero risk of pharmacological interactions or mood destabilization.
Psychotherapy is equally or more effective than pharmacotherapy for PTSD and is the treatment of choice in medically complex scenarios.

Anahtar Kavram

First-line management of PTSD in patients with complex pharmacological contraindications (e.g., Bipolar I disorder, use of serotonergic supplements) relies on trauma-focused psychotherapy to avoid severe adverse events like serotonin syndrome or manic switch.
Bu soruyu puanla